Founded by physician-scientists, Pyogenix bridges cutting-edge molecular diagnostics with real-world impact. We understand the consequences of diagnostic delay and the overuse of broad-spectrum antibiotics—because we’ve seen them firsthand. That’s why we created the R2 System: a culture-free, hypothesis-free diagnostic platform designed to rapidly identify bacterial pathogens in critically ill patients.

Our interdisciplinary team combines clinical insight with bioengineering and AI to build solutions that matter—at the bedside and beyond.